Roger Dansey
Net worth: 83 297 $ as of 30/04/2026
Net worth: 83 297 $ as of 30/04/2026
Presently, Roger D. Dansey occupies the position of Chief Medical Officer for Seagen Inc. In the past Dr. Dansey held the position of Vice President-Oncology Clinical Research at Gilead Sciences, Inc. and SVP & Head-Therapeutic Area at Merck Research Laboratories Massachusetts LLC. Dr. Dansey received a doctorate from the University of the Witwatersrand.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/01/2026 | 15,532 ( 0.04% ) | 73 311 $ | 30/04/2026 | |
| 24/03/2026 | 8,916 ( 0.01% ) | 9 986 $ | 30/04/2026 | |
| 15/05/2026 | 0 ( -.--% ) | - $ | 30/04/2026 |
| Companies | Position | Start |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 13/05/2021 |
| BICYCLE THERAPEUTICS PLC | Director/Board Member | 08/09/2025 |
| NURIX THERAPEUTICS, INC. | Director/Board Member | 10/11/2025 |
Inovio, Inc.
Inovio, Inc. Packaged SoftwareTechnology Services Operates as an online payment platform | Director/Board Member | - |
Ultrahuman Eight Ltd.
Ultrahuman Eight Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer-related medicine | Director/Board Member | - |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| KRONOS BIO, INC. | Director/Board Member | 20/06/2025 |
| PFIZER INC. | Corporate Officer/Principal | 05/02/2025 |
| SEAGEN INC. | Chief Executive Officer | 09/11/2022 |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Inovio, Inc.
Inovio, Inc. Packaged SoftwareTechnology Services Operates as an online payment platform | Technology Services |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Kronos Bio, Inc.
Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Shasqi, Inc.
Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Ultrahuman Eight Ltd.
Ultrahuman Eight Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer-related medicine | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition